logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Urticaria

    Medications for Urticaria

    FiltersReset Filters
    18 results

    • carbinoxamine maleate

      (Carbinoxamine Maleate)
      Biocomp Pharma, Inc.
      Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, dermatographism, as adjunct therapy for anaphylactic reactions, and to reduce the severity of allergic reactions to blood or plasma.

    • clemastine fumarate

      (Clemastine Fumarate)
      Genus Lifesciences
      Usage: Clemastine Fumarate Tablets USP, 2.68 mg are indicated for relieving symptoms of allergic rhinitis (sneezing, runny nose, itching, tearing) and mild, uncomplicated allergic skin reactions such as urticaria and angioedema, specifically at the 2.68 mg dosage.

    • cyproheptadine hydrochloride

      (Cyproheptadine Hydrochloride)
      Bayshore Pharmaceuticals LLC
      Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, cold urticaria, dermatographism, and as adjunctive therapy for anaphylactic reactions after initial control with epinephrine.

    • cyproheptadine hydrochloride

      (Cyproheptadine Hydrochloride)
      Rising Pharma Holdings, Inc.
      Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, cold urticaria, dermatographism, ameliorating allergic reactions to blood, and as an adjunctive therapy for anaphylactic reactions after acute management.

    • cyproheptadine hydrochloride

      (Cyproheptadine Hydrochloride)
      Patrin Pharma, Inc.
      Usage: The drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, cold urticaria, dermatographism, and as an adjunctive therapy for anaphylactic reactions after initial treatment with epinephrine and standard measures.

    • cyproheptadine hydrochloride

      (Cyproheptadine Hydrochloride)
      Amneal Pharmaceuticals of New York LLC
      Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, amelioration of allergic reactions to blood, cold urticaria, dermatographism, and as an adjunctive therapy for anaphylactic reactions after initial management.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Hikma Pharmaceuticals USA Inc.
      Usage: This drug is indicated for intravenous or intramuscular use in various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), allergic states, skin diseases, and gastrointestinal issues. It also addresses respiratory, hematologic, neoplastic, and nervous system disorders, with specific applications for intra-articular, soft tissue, and intralesional administration.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Mylan Institutional LLC
      Usage: This drug is indicated for various conditions, including adrenal insufficiencies, rheumatic disorders, collagen diseases, severe allergic reactions, ophthalmic, gastrointestinal, respiratory, hematologic, and neoplastic diseases, and for reducing edema. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally, depending on the condition.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Amneal Pharmaceuticals LLC
      Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, allergic states, gastrointestinal diseases, respiratory diseases, hematologic disorders, and certain dermatologic and ophthalmic diseases. It can be administered intravenously, intramuscularly, intra-articular, or intralesionally for acute episodes and management of chronic conditions.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Civica, Inc.
      Usage: This drug is indicated for various conditions, including endocrine disorders (like adrenocortical insufficiency), rheumatic and collagen diseases, severe allergic reactions, dermatologic and gastrointestinal diseases, respiratory issues, hematologic conditions, neoplastic diseases, and neurological disorders. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally as appropriate.